New biopsy key in guiding treatment of metastatic cancer ‘Powerful drug’ boosts melanoma survivalMonoclonal antibody ipilimumab a rare success, but some patients die from the treatment Sentinel node histology not useful in predicting breast cancer survival Major trial looking at immunohistochemistry does not support use of sophisticated test in guiding treatment Bisphosphonates unlikely to cause esophageal cancer Targeted agent looks promising in treating pediatric brain cancer Drug works on ‘Sonic hedgehog pathway’ found in medulloblastomas, other cancers Clinical Notes: Canadian testicular cancer guidelines Guidelines developed on diagnosis, management of germ cell testicular cancer. X-ray absorptiometry an option for breast density evaluation Statins may cut prostate cancer recurrence risk Thalidomide approved in Canada for multiple myeloma Yondelis: new drug for ovarian cancer Janssen-Ortho is introducing Yondelis (trabectedin for injection, 1 mg/vial) for the treatment of patients with platinum-sensitive ovarian cancer. First Previous 60 61 62 63 64 Next Last
